Skip to main content

Table 2 Individual data of patients with heart exposure from prophylactic breast radiation therapy.

From: Can prophylactic breast irradiation contribute to cardiac toxicity in patients with prostate cancer receiving androgen suppressing drugs?

Patientnr.

Age (years)

Heart disease

CT-based beam energy

Skin-heart distance

Exposure

1

65

yes

12 MeV

5,1 cm

Moderate

2

65

yes

9 MeV

4,2 cm

Moderate

3

75

yes

9 MeV

4,0 cm

Distinct

4

75

no

6 MeV

2,6 cm

Moderate

5

75

no

9 MeV

3,7 cm

Distinct

6

65

no

6 MeV

3,1 cm

Moderate**

7

75

no

6 MeV

3,8 cm

Moderate**

8

75

yes

6 MeV

4,0 cm

Moderate**

9

75

yes

6 MeV

3,9 cm

Moderate**

10

75

yes

6 MeV

3,3 cm

Distinct**

11*

64

no

6 MeV

3,9 cm

Moderate**

12*

83

no

6 MeV

3,9 cm

Moderate**

  1. * prostate cancer patient
  2. **when using the standard 9 MeV beam in the absence of CT scan information